Commonwealth Equity Services’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,793
| Closed | -$213K | – | 3767 |
|
|
2022
Q1 | $213K | Sell |
2,793
-2,261
| -45% | -$172K | ﹤0.01% | 3279 |
|
|
2021
Q4 | $304K | Buy |
+5,054
| New | +$304K | ﹤0.01% | 2960 |
|
|
2021
Q2 | – | Sell |
-3,229
| Closed | -$226K | – | 3560 |
|
|
2021
Q1 | $226K | Sell |
3,229
-150
| -4% | -$10.5K | ﹤0.01% | 3030 |
|
|
2020
Q4 | $202K | Buy |
+3,379
| New | +$202K | ﹤0.01% | 2916 |
|
|
2016
Q1 | – | Sell |
-3,223
| Closed | -$247K | – | 2250 |
|
|
2015
Q4 | $247K | Buy |
+3,223
| New | +$247K | ﹤0.01% | 1742 |
|
|
2015
Q3 | – | Sell |
-3,640
| Closed | -$257K | – | 2205 |
|
|
2015
Q2 | $257K | Buy |
3,640
+956
| +36% | +$67.5K | ﹤0.01% | 1744 |
|
|
2015
Q1 | $238K | Buy |
2,684
+245
| +10% | +$21.7K | ﹤0.01% | 1785 |
|
|
2014
Q4 | $216K | Hold |
2,439
| – | – | ﹤0.01% | 1798 |
|
|
2014
Q3 | $236K | Buy |
2,439
+9
| +0.4% | +$871 | ﹤0.01% | 1721 |
|
|
2014
Q2 | $223K | Buy |
+2,430
| New | +$223K | ﹤0.01% | 1751 |
|